Novartis Pharmaceuticals H-1B Salaries 2026
102 certified H-1B Labor Condition Applications for full-time roles at Novartis Pharmaceuticals, decided Jul 1, 2025 – Jun 30, 2026. Median offered salary $143,812.
$143,812Median salary
$112,96525th percentile
$169,54175th percentile
102Filings
Novartis Pharmaceuticals H-1B salaries by job title
| Job title | Filings | Median |
|---|---|---|
| Principal Biostatistician | 13 | $112,965 |
| Expert Science & Technology | 4 | $113,433 |
| Senior Principal Biostatistician | 4 | $120,412 |
| Associate Director Biostatistics | 2 | $175,781 |
| Director Resource Optimization Commercial | 2 | $223,142 |
| Director Emerging Data Products Ns | 2 | $196,592 |
| Director Forecasting Cv | 2 | $169,541 |
| Finance Manager | 2 | $92,986 |
| Business Planning and Analysis Manager | 2 | $92,986 |
| Senior Global Program Safety Lead | 2 | $183,186 |
| Associate Director Business Applications Product Owner | 2 | $126,818 |
| Manager Hcp Education Delivery | 1 | $143,250 |
| Ed Portfolio & Early Pipeline Strategy | 1 | $199,410 |
| Ad Integrated Field Deployment & Gtm Analytics | 1 | $139,506 |
| Associate Director Integrated Field Targeting & Nba | 1 | $169,541 |
Top cities
| City | Filings | Median |
|---|---|---|
| East Hanover, NJ | 91 | $156,832 |
| Cambridge, MA | 6 | $125,154 |
| Durham, NC | 3 | $112,757 |
| Morris Plains, NJ | 2 | $119,120 |
Wage levels
Prevailing-wage level the employer selected (I = entry, IV = fully competent).
Median prevailing wage on these filings: $142,990.
Recent Novartis Pharmaceuticals H-1B filings
Latest 100 of 102 filings by decision date. Salary is the offered wage rate (annualised); "to" shows the top of a range when given.
| Certified | Job title | Salary |
|---|---|---|
| 2026-06-24 | Director, Forecasting - RENAL PNH | $109,491 |
| 2026-06-11 | Director, Product Strategy Lead LCM - Immunology | $169,541 |
| 2026-06-09 | Business Planning and Analysis Manager | $112,778 |
| 2026-06-09 | Finance Manager | $112,778 |
| 2026-06-08 | Associate Director, RA Transaction Records | $169,541 |
| 2026-06-08 | Associate Director, NPS Service Strategy & Standards | $183,186 |
| 2026-06-04 | AD, Field Ops Excellence | $169,541 |
| 2026-06-03 | Director, Forecasting-CV | $169,541 |
| 2026-05-26 | Associate Director, Healthcare Provider Marketing | $199,410 |
| 2026-05-21 | Associate Director, Statistical Programming | $145,454 |
| 2026-05-18 | Senior Principal Clinical Data Scientist | $139,506 |
| 2026-05-15 | Associate Director, AI Technology Lead | $185,723 |
| 2026-05-12 | Senior Principal Biostatistician | $112,965 |
| 2026-04-24 | Associate Director, Lead Consultant | $191,422 |
| 2026-04-24 | QC Systems and Services Manager | $130,289 |
| 2026-04-22 | Associate Director Biostatistics | $175,781 |
| 2026-04-22 | Associate Director, AI Tech Lead | $185,723 |
| 2026-04-17 | Director, Emerging Data Products - NS | $169,541 |
| 2026-04-16 | Senior Principal Biostatistician | $112,965 |
| 2026-04-14 | Senior Principal Biostatistician | $144,373 |
| 2026-04-03 | Associate Director, Payer & Pricing Strategy | $169,541 |
| 2026-04-03 | Associate Director, Patient and Provider Analytics - CRM | $169,541 |
| 2026-04-03 | Director, Business Excellence - Immunology | $169,541 |
| 2026-04-03 | Principal Biostatistician | $112,965 |
| 2026-04-03 | Business Planning and Analysis Manager | $73,195 |
| 2026-04-03 | Director, Payer Insights | $169,541 |
| 2026-04-03 | Principal Biostatistician | $112,965 |
| 2026-04-03 | Director, Decision Science | $223,142 |
| 2026-03-31 | Senior Principal Statistician | $112,965 |
| 2026-03-31 | AD, Patient and Provider Analytics - CRM | $169,541 |
| 2026-03-31 | Associate Director, Patient & Provider Analytics | $169,541 |
| 2026-03-31 | Finance Manager | $73,195 |
| 2026-03-31 | Clinical Trial Leader I | $141,398 |
| 2026-03-31 | Principal Biostatistician | $112,965 |
| 2026-03-31 | Expert CMC Statistics | $112,965 |
| 2026-03-30 | Principal Biostatistician | $112,965 |
| 2026-03-30 | Associate Clinical Development Medical Director | $116,730 |
| 2026-03-27 | Principal Biostatistician | $112,965 |
| 2026-03-27 | Principal Biostatistician | $112,965 |
| 2026-03-27 | Principal Biostatistician | $112,965 |
| 2026-03-27 | Associate Director, PSC Operations Insights | $169,541 |
| 2026-03-27 | AD, Integrated Field Execution Effectiveness - CE | $169,541 |
| 2026-03-27 | Director, Product Strategy Counsel | $156,832 |
| 2026-03-27 | Study Leader | $141,398 |
| 2026-03-26 | Expert Science & Technology | $96,054 |
| 2026-03-26 | Principal Biostatistician | $89,731 |
| 2026-03-26 | Principal Biostatistician | $112,965 |
| 2026-03-26 | Associate Expert Potency | $89,419 |
| 2026-03-26 | Director, Forecasting-CV | $169,541 |
| 2026-03-25 | Director, Emerging Data Products - NS | $223,642 |
| 2026-03-25 | Associate Director, Business Performance - CRM | $169,541 |
| 2026-03-25 | FDP Associate | $112,778 |
| 2026-03-25 | Operational Health Project Manager | $129,709 |
| 2026-03-25 | Head of Strategy, US | $223,142 |
| 2026-03-17 | Technology Product Director | $223,642 |
| 2026-03-16 | Director, Integrated Field Targeting and NBA - CE | $169,541 |
| 2026-02-27 | Senior Product Manager - Novartis Patient Support | $126,818 |
| 2026-02-18 | Associate Director, Monitoring and Standards | $169,541 |
| 2026-01-13 | Senior Principal Product Service Manager | $126,818 |
| 2026-01-13 | Global Regulatory Submission Manager | $141,190 |
| 2025-12-29 | Director, Resource Optimization Commercial | $223,142 |
| 2025-12-17 | Director, AI Use Case Lead | $185,723 |
| 2025-12-17 | Director, Resource Optimization Commercial | $223,142 |
| 2025-12-03 | Director - Decision Science, Immunology Product Lead | $138,466 |
| 2025-12-01 | BPO Order Management & Finance, C&G | $169,541 |
| 2025-11-26 | Product Strategy Lead, Stroke Prevention in A-Fib | $199,410 |
| 2025-11-19 | Expert Science & Technology | $122,450 |
| 2025-11-18 | Senior Principal Biostatistician | $127,858 |
| 2025-11-17 | Associate Director, Integrated Field Targeting & NBA | $169,541 |
| 2025-11-14 | ED, Portfolio & Early Pipeline Strategy | $199,410 |
| 2025-11-14 | AD, Integrated Field Deployment & GTM Analytics | $139,506 |
| 2025-11-14 | Associate Director, Biostatistics | $175,781 |
| 2025-11-07 | Expert Science & Technology | $112,757 |
| 2025-11-06 | Manager, HCP Education Delivery | $143,250 |
| 2025-11-06 | Principal Biostatistician | $127,858 |
| 2025-09-30 | Director, Integrated Field Insights & Analytics | $169,541 |
| 2025-09-23 | Principal Biostatistician | $144,373 |
| 2025-09-15 | Principal Biostatistician | $144,373 |
| 2025-09-12 | Expert Science & Technology | $114,109 |
| 2025-09-09 | Sr. Global Program Safety Lead | $183,186 |
| 2025-09-08 | Sr. Global Program Safety Lead | $183,186 |
| 2025-09-04 | Associate Director, NPS Product Management | $158,974 |
| 2025-09-04 | R&D/Tech Dev Quality Lead, Compliance | $142,730 |
| 2025-09-02 | Principal Biostatistician | $112,965 |
| 2025-08-22 | Associate Director, Performance Reporting | $109,491 |
| 2025-08-15 | Manager, Performance Reporting | $109,491 |
| 2025-08-05 | Associate Director, Business Performance | $169,541 |
| 2025-07-29 | Associate Director, Business Applications Product Owner | $126,818 |
| 2025-07-28 | Associate Director, Business Applications Product Owner | $126,818 |
| 2025-07-28 | AD,Software Architect,Full Stack,RWD Sol | $187,741 |
| 2025-07-25 | Sr. Principal AQS Tech & Scientific Com | $161,803 |
| 2025-07-11 | Associate Director, Web Platform Ops & Solutions Designs | $186,056 |
| 2025-07-11 | Associate Director, PM QA | $118,435 |
| 2025-07-11 | Senior Manager, Functional Reporting | $126,818 |
| 2025-07-11 | Associate Director, Emerging Data Products | $139,506 |
| 2025-07-10 | Associate Director Patient Marketing Vijoice | $156,894 |
| 2025-07-09 | Director, AI Engineering | $223,642 |
| 2025-07-07 | Associate Director, Product Adoption | $170,373 |
| 2025-07-07 | Director, US Forecasting | $111,966 |
| 2025-07-07 | Sr. Multi-Discipline Engineer | $107,952 |
Employer names as filed: NOVARTIS PHARMACEUTICALS CORPORATION; Novartis Pharmaceuticals Corporation. Name variants that differ only in case, punctuation or legal suffix (LLC, Inc., Corp.) are merged. Separate legal entities are listed separately. These are wages offered on certified LCAs, not actual pay.